Silk Road Medical Shares Surge Premarket on Boston Scientific Deal
By Colin Kellaher
Shares of Silk Road Medical rose sharply in premarket trading Tuesday after the medical-device maker agreed to be acquired by larger peer Boston Scientific for about $1.26 billion.
Boston Scientific is paying $27.50 a share in cash for Silk Road, a 27% premium to Monday's closing price of $21.67 for the Sunnyvale, Calif., company.
Silk Road shares were recently changing hands at $26.60, up nearly 23%, in premarket trading.
The deal, which carries an enterprise value of about $1.16 billion including Silk Road's cash position, is slated to close by the end of the year.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
June 18, 2024 07:41 ET (11:41 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations